The expression of VISTA on CD4+ T cells associate with poor prognosis and immune status in non-small cell lung cancer patients. Biomol Biomed [Internet]. 2022 Sep. 16 [cited 2024 May 4];22(5):707-15. Available from: https://www.bjbms.org/ojs/index.php/bjbms/article/view/6531